Key facts
- This page summarizes Andrew J. Last's Form 4 filing for BIO-RAD LABORATORIES, INC. (BIO).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 30 Apr 2024, 17:53.
Andrew J. Last - 29 Apr 2024 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)
- Reporting relationship
- EVP, Chief Operating Officer
- Issuer ticker
- BIO
- Reported as of
- 29 Apr 2024
- Net transaction value
- -$98,928
- SEC form
- 4
- Accepted by SEC
- 30 Apr 2024, 17:53:07 UTC
- Prior SEC filing
- 12 Mar 2024
- Next SEC filing
- 03 Jul 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Andrew J. Last
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Andrew J. Last filed Form 4 for BIO-RAD LABORATORIES, INC. (BIO) on 30 Apr 2024.
Change
- Previous filing in this sequence was filed on 12 Mar 2024.
- Current net transaction value: -$98,928.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIO BIOB
transaction
Bio-Rad A Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +1,000
- Change %
- +20%
- Price
- $0.000000
- Shares after
- 6,077
- Date
- 29 Apr 2024
- Ownership
- Direct
- Footnotes
- F1, F2
BIO BIOB
transaction
Bio-Rad A Common Stock
Tax liability
- Transaction value
- $98,928
- Shares
- -357
- Change %
- -5.9%
- Price
- $277.11
- Shares after
- 5,720
- Date
- 29 Apr 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIO BIOB
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -1,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 29 Apr 2024
- Ownership
- Direct
- Underlying class
- Bio-Rad A Common Stock
- Underlying amount
- 1,000
- Exercise price
- $0.000000
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Shares of Class A common stock acquired on the vesting of restricted stock units.
Footnote F2
Includes 9.7660 and 27.5220 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2023 and 03/31/2024, respectively.
Footnote F3
Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
Footnote F4
On April 29, 2019, the reporting person was granted 5,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.